"Comparison of MRCP a ERCP in Diagnosis of Choledocholithiasis"@en . . "59" . "Kiani\u010Dka, Bohuslav" . . . "Srovn\u00E1n\u00ED MRCP a ERCP v diagnostice choledocholiti\u00E1zy" . . "\u0158ih\u00E1\u010Dek, Ivan" . "0042-773X" . "Mikulicov\u00E1, Radom\u00EDra" . "\u00DAvod: Choledocholiti\u00E1za je nej\u010Dast\u011Bj\u0161\u00ED p\u0159\u00ED\u010Dinou obstrukce \u017Elu\u010Dov\u00FDch cest. Ka\u017Ed\u00E1 z vy\u0161et\u0159ovac\u00EDch metod pou\u017E\u00EDvan\u00FDch v jej\u00ED diagnostice m\u00E1 sv\u00E9 v\u00FDhody a nev\u00FDhody. C\u00EDl pr\u00E1ce: C\u00EDlem t\u00E9to prospektivn\u00ED studie je porovnat endoskopickou retrogr\u00E1dn\u00ED cholangiopankreatikografii a magnetickou rezonan\u010Dn\u00ED cholangiopankreatikografii v diagnostice choledocholiti\u00E1zy, a to na z\u00E1klad\u011B vlastn\u00EDch zku\u0161enost\u00ED a liter\u00E1rn\u00EDch dat. Soubor nemocn\u00FDch a metodika: Studium souboru prob\u00EDhalo od za\u010D\u00E1tku roku 2007 do konce roku 2012 (tedy 6 let). V pr\u00E1ci bylo prospektivn\u011B hodnoceno 45 pacient\u016F (v\u011Bkov\u00E9 rozmez\u00ED 28-72 let) s projevy bili\u00E1rn\u00ED obstrukce, kdy tito nemocn\u00ED m\u011Bli provedenu nejprve magnetickou rezonan\u010Dn\u00ED cholangiopankreatikografii a n\u00E1sledn\u011B pak endoskopickou retrogr\u00E1dn\u00ED cholangiopankreatikografii. V\u00FDsledky: Senzitivita, specificita a diagnostick\u00E1 p\u0159esnost magnetick\u00E9 rezonan\u010Dn\u00ED cholangiopankreatikografie byla v na\u0161em souboru i podle liter\u00E1rn\u00EDch dat ni\u017E\u0161\u00ED oproti endoskopick\u00E9 retrogr\u00E1dn\u00ED cholangiopankreatikografii (92 %, 91 % resp. 93 %). Z\u00E1v\u011Br: Vzhledem k frekvenci komplikac\u00ED (a to v n\u011B\u00ADkte\u00ADr\u00FDch p\u0159\u00EDpadech i z\u00E1va\u017En\u00FDch) po endoskopick\u00E9 retrogr\u00E1dn\u00ED cholangiopankreatikografii je i p\u0159es ni\u017E\u0161\u00ED senzitivitu magnetick\u00E1 rezonan\u010Dn\u00ED cholangiopankreatikografie metodou volby v diagnostice choledocholiti\u00E1zy pomoc\u00ED neinvazivn\u00EDch metod, na z\u00E1klad\u011B kter\u00E9 lze pacienty n\u00E1sledn\u011B indikovat k terapeutick\u00E9 endoskopick\u00E9 retrogr\u00E1dn\u00ED cholangiopankreatikografii."@cs . . . . "Kyselov\u00E1, Hana" . . . "Comparison of MRCP a ERCP in Diagnosis of Choledocholithiasis"@en . "Bajgarov\u00E1, Barbora" . "RIV/00159816:_____/13:00060766!RIV14-MZ0-00159816" . "\u00DAvod: Choledocholiti\u00E1za je nej\u010Dast\u011Bj\u0161\u00ED p\u0159\u00ED\u010Dinou obstrukce \u017Elu\u010Dov\u00FDch cest. Ka\u017Ed\u00E1 z vy\u0161et\u0159ovac\u00EDch metod pou\u017E\u00EDvan\u00FDch v jej\u00ED diagnostice m\u00E1 sv\u00E9 v\u00FDhody a nev\u00FDhody. C\u00EDl pr\u00E1ce: C\u00EDlem t\u00E9to prospektivn\u00ED studie je porovnat endoskopickou retrogr\u00E1dn\u00ED cholangiopankreatikografii a magnetickou rezonan\u010Dn\u00ED cholangiopankreatikografii v diagnostice choledocholiti\u00E1zy, a to na z\u00E1klad\u011B vlastn\u00EDch zku\u0161enost\u00ED a liter\u00E1rn\u00EDch dat. Soubor nemocn\u00FDch a metodika: Studium souboru prob\u00EDhalo od za\u010D\u00E1tku roku 2007 do konce roku 2012 (tedy 6 let). V pr\u00E1ci bylo prospektivn\u011B hodnoceno 45 pacient\u016F (v\u011Bkov\u00E9 rozmez\u00ED 28-72 let) s projevy bili\u00E1rn\u00ED obstrukce, kdy tito nemocn\u00ED m\u011Bli provedenu nejprve magnetickou rezonan\u010Dn\u00ED cholangiopankreatikografii a n\u00E1sledn\u011B pak endoskopickou retrogr\u00E1dn\u00ED cholangiopankreatikografii. V\u00FDsledky: Senzitivita, specificita a diagnostick\u00E1 p\u0159esnost magnetick\u00E9 rezonan\u010Dn\u00ED cholangiopankreatikografie byla v na\u0161em souboru i podle liter\u00E1rn\u00EDch dat ni\u017E\u0161\u00ED oproti endoskopick\u00E9 retrogr\u00E1dn\u00ED cholangiopankreatikografii (92 %, 91 % resp. 93 %). Z\u00E1v\u011Br: Vzhledem k frekvenci komplikac\u00ED (a to v n\u011B\u00ADkte\u00ADr\u00FDch p\u0159\u00EDpadech i z\u00E1va\u017En\u00FDch) po endoskopick\u00E9 retrogr\u00E1dn\u00ED cholangiopankreatikografii je i p\u0159es ni\u017E\u0161\u00ED senzitivitu magnetick\u00E1 rezonan\u010Dn\u00ED cholangiopankreatikografie metodou volby v diagnostice choledocholiti\u00E1zy pomoc\u00ED neinvazivn\u00EDch metod, na z\u00E1klad\u011B kter\u00E9 lze pacienty n\u00E1sledn\u011B indikovat k terapeutick\u00E9 endoskopick\u00E9 retrogr\u00E1dn\u00ED cholangiopankreatikografii." . "CZ - \u010Cesk\u00E1 republika" . "Srovn\u00E1n\u00ED MRCP a ERCP v diagnostice choledocholiti\u00E1zy"@cs . "Introduction: Choledocholithiasis is the most common cause of biliary obstruction. Each of the testing methods used in its diagnosis has its advantages and disadvantages. Objective of the study: The objective of this prospective study is to compare endoscopic retrograde cholangiopancreatography with magnetic resonance cholangiopancreatography in the diagnosis of choledocholithiasis on the basis of own experience and literature data. Set of patients and methodology: The set was studied from the beginning of 2007 to the end of 2012 (i.e. six years). The study assessed prospectively 45 patients (age range 28-72 years) with symptoms of biliary obstruction, who first underwent magnetic resonance cholangiopancreatography and subsequently endoscopic retrograde cholangiopancreatography. Results: The sensitivity, specificity and diagnostic accuracy of magnetic resonance cholangiopancreatography was lower, both in our set of patients and according to the literature data, compared to the endoscopic retrograde cholangiopancreatography (92%, 91% or 93 %). Conclusion: Considering the frequency of complications (in some cases serious ones) following endoscopic retrograde cholangiopancreatography, the magnetic resonance cholangiopancreatography is, in spite of its lower sensitivity, the method of choice in the diagnosis of choledocholithiasis by means of non\u2011invasive methods, on the basis of which it is possible to refer the patients subsequently for therapeutic endoscopic retrograde cholangiopancreatography."@en . . . . "Srovn\u00E1n\u00ED MRCP a ERCP v diagnostice choledocholiti\u00E1zy" . . . . "[BFF2A3E25D81]" . . "Srovn\u00E1n\u00ED MRCP a ERCP v diagnostice choledocholiti\u00E1zy"@cs . . "I, P(ED1.100/02/0123)" . . . "4"^^ . "\u0160p\u00E1c, Ji\u0159\u00ED" . . "107319" . "8"^^ . . . "Choledocholithiasis; ERCP; MRCP"@en . . "5" . "Van\u00ED\u010Dek, Ji\u0159\u00ED" . "Vnit\u0159n\u00ED l\u00E9ka\u0159stv\u00ED" . "RIV/00159816:_____/13:00060766" . "7"^^ . "Trna, J." .